Re: The Challenges of bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients

Griebling Tomas L.

首页> 外文期刊>The Journal of Urology >Re: The Challenges of bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients

【24h】

Re: The Challenges of bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients

机译：Re：钙愈合 - 吐仑（BCG）治疗高风险非肌肉侵袭性膀胱癌治疗患者的挑战

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2019年第5期|共1页
作者
Griebling Tomas L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: The Challenges of bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients [J] . The Journal of Urology . 2020,第6期

机译：Re：钙愈合 - 吐仑（BCG）治疗高风险非肌肉侵袭性膀胱癌治疗患者的挑战
2. The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients [J] . Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, Journal of geriatric oncology . 2018,第5期

机译：老年患者高风险非肌肉侵袭性膀胱癌治疗升级 - 吐仑（BCG）治疗脑胆肿的挑战
3. Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non-Muscle-invasive Bladder Cancer in Intermediate-and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial [J] . Solsona Eduardo, Madero Rosario, Chantada Venancio, European urology . 2015,第3期

机译：丝裂霉素C加芽孢杆菌卡介苗（BCG）的顺序组合在中，高危患者中对非肌肉浸润性膀胱癌患者更有效，但比单独的BCG更具毒性：CUETO 93009的最终结果（随机分组）试用版
4. Determination of Bacillus Calmette-Guerin Concentration Integrated in Delivery Materials for Intravesical Infusion Therapy of Superficial Bladder Cancer [C] . Chengge Wu, Kangning Sun, Aimin Li International Conference on Advances in Materials and Manufacturing . 2013

机译：浅析浅析浅表膀胱癌膀胱内输液治疗
5. Understanding treatment-related symptoms, symptom management techniques, and symptom management self-efficacy in a sample of non-muscle invasive bladder cancer patients [D] . Hinojosa-Lindsey, Marilyn 2010

机译：了解非肌肉浸润性膀胱癌患者样本中与治疗相关的症状，症状管理技术和症状管理自我效能
6. Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer? [O] . Hyeong Dong Yuk, Chang Wook Jeong, Cheol Kwak, -1

机译：对于高危非肌肉浸润性膀胱癌患者经反复经尿道膀胱肿瘤切除术后是否应对T0患者进行膀胱Calmette-Guerin芽孢杆菌（BCG）治疗？
7. Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial [O] . Eduardo Solsona, Rosario Madero, VenancioChantada 2015

机译：回复：丝裂霉素C加卡介苗（BCG）的顺序组合比中等和高风险患者的非肌肉浸润性膀胱癌患者中的BCG更有效但更有毒：CUETO 93009的最终结果，a随机前瞻性试验

Re: The Challenges of bacillus of Calmette-Guerin (BCG) Therapy for High Risk Non Muscle Invasive Bladder Cancer Treatment in Older Patients

著录项

引文网络

相似文献

相关主题

期刊订阅